Analysis of proliferating cell fraction determined by monoclonal antibody to M1-subunit ribonucleotide reductase and Ki-67 in relation to p53 protein expression in fine-needle aspirates from non-Hodgkin's lymphomas
Authors:
- 9 October 2000
- journal article
- research article
- Published by Wiley in Cytopathology
- Vol. 11 (5) , 290-301
Abstract
The purpose of this study was to analyse the proliferative fraction with the monoclonal antibody M1‐R‐R to M1‐subunit ribonucleotide reductase and with MIB‐1 to Ki‐67 antigen in relation to p53 protein expression in fine needle aspirates from B‐cell non‐Hodgkin's lymphomas. One hundred and thirty‐seven cases, previously diagnosed and sub‐typed according to the Kiel classification and characterized by immunophenotyping, were included in the study. The M‐1 subunit ribonucleotide reductase (M1‐R‐R), Ki‐67 and p53 antigens were detected using monoclonal antibodies on stored cytospin preparations. There was a good correlation (r = 0.72) between Ki‐67 and M1‐R‐R positive cell fraction in both high and low grade lymphomas. High‐grade lymphomas had a median percentage of M1‐R‐R/MIB‐1 positive cells of 53.0/73.0 for lymphoblastic, 61.0/52.0 for immunoblastic and 33.5/41.0 for centroblastic lymphomas, respectively. In low grade lymphomas figures of median percentage of M1‐R‐R/MIB‐1 were 9.0/15.0 for centroblastic/centrocytic, 11.0/9.5 for chronic lymphocytic leukaemia, 16.0/27.0 for centrocytic and 12.0/9.0 for immunocytomas, respectively. The median percentages of M1‐R‐R/MIB‐1 for high and low grade lymphomas were 37.0/50.5 and 11.0/12.0, respectively. In the p53 positive cases the proliferation rate as measured by staining for M1‐R‐R and MIB‐1 was higher than in p53 negative cases, but the difference was not statistically significant. The results show that cytospin material obtained by fine needle aspiration and stored at −70 °C for years can be used reliably for both peroxidase‐avidin‐biotin and three‐step alkaline phosphatase immunocytochemical staining. In addition, proliferation fraction determined by M1‐R‐R monoclonal antibody staining correlates well with that measured by an established marker for cell proliferation, the Ki‐67 antibody. However, the proliferation fraction as measured by the two antibodies differs in the various subtypes of non‐Hodgkin's lymphoma which indicates that they may contribute different prognostic information.Keywords
This publication has 18 references indexed in Scilit:
- p53 Protein Expression in Gastrointestinal LymphomasOncology, 1997
- Proliferating cell nuclear antigen (PCNA) in non-hodgkin’s lymphomas: correlation with working formulation and kiel classification in formalin-fixed paraffin-embedded materialPathology, 1996
- DNA content and expression of PCNA and p53 in Hodgkin's disease and Hodgkin's‐like B‐ceil lymphomaAPMIS, 1994
- MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.Journal of Clinical Pathology, 1994
- P53 protein expression in lymphomas and reactive lymphoid tissueThe Journal of Pathology, 1992
- S-Phase-specific expression of mammalian ribonucleotide reductase R1 and R2 subunit mRNAsBiochemistry, 1990
- Cell cycle-dependent reactivity with the monoclonal antibody Ki-67 during myeloid cell differentiationExperimental Cell Research, 1988
- UPDATED KIEL CLASSIFICATION FOR LYMPHOMASThe Lancet, 1988
- The cell cycle associated change of the Ki‐67 reactive nuclear antigen expressionJournal of Cellular Physiology, 1987
- Monoclonal Antibodies Against Mammalian Ribonucleotide Reductase.Acta Chemica Scandinavica, 1982